Advisory Services Network’s Definium Therapeutics DFTX Stock Holding History

Advisory Services Network’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,659	Closed	-$50.3K	–	3686
2026 Q1	$50.3K	Buy	+2,659	New	+$45.1K	﹤0.01%	2623
2025 Q4	–	Sell	-656	Closed	-$7.74K	–	3332
2025 Q3	$7.74K	Buy	+656	New	+$6.12K	﹤0.01%	3375
2024 Q1	–	Sell	-9	Closed	-$33	–	2796
2023 Q4	$33	Buy	+9	New	+$27	﹤0.01%	3827
2023 Q2	–	Sell	-9	Closed	-$29	–	2772
2023 Q1	$29	Sell	9 -16	-64%	-$53	﹤0.01%	3942
2022 Q4	$55	Buy	+25	New	+$69	﹤0.01%	3935

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Advisory Services Network's DFTX Position: Q2 2026 in Review

Advisory Services Network sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 2,659 shares — an estimated $50.3K sold.

Advisory Services Network first reported a position in DFTX in Q4 2022 and held it in 5 quarters. The position peaked at $50.3K in Q1 2026. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Advisory Services Network reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 2,659 Definium Therapeutics shares in Q2 2026, an estimated $50.3K.
Advisory Services Network first reported a position in Definium Therapeutics in Q4 2022 and held it in 5 quarters.
Advisory Services Network's Definium Therapeutics position peaked at $50.3K in Q1 2026.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.